Why the study?
Does the chymase inhibitor NK3201 prevent neointimal hyperplasia after balloon injury in dogs?
Does the chymase inhibitor NK3201 prevent neointimal hyperplasia after balloon injury in dogs?
Chymase inhibition prevents neointimal hyperplasia after balloon injury in a canine model, likely via inhibition of MMP-2 activation.
Chymase inhibition may limit neointimal hyperplasia after vascular injury; hypothesis-generating for human restenosis prevention.
Chymase is known to generate angiotensin II in the vascular wall. In this study we investigated a novel role for chymase other than angiotensin II production in vascular proliferation after balloon injury. Chymase promoted the migration of vascular smooth muscle cells in the matrix-coated invasion chambers and activated promatrix metalloproteinase-2 obtained from the culture medium of vascular smooth muscle cells. Two weeks after balloon injury, significant neointimal formation was found in dog carotid arteries. After injury, active matrix metalloproteinase-2 was increased in parallel with the augmentation of chymase activity that was seen in the proliferating region of the vascular wall. The oral administration of NK3201 (1 mg/kg per day), a chymase inhibitor, prevented neointimal formation and significantly suppressed both active matrix metalloproteinase-2 and chymase activities 2 weeks after injury. These results suggest that chymase inhibitors can prevent the development of intimal hyperplasia via the inhibition of matrix metalloproteinase-2 activation in balloon-injured arteries.
No takes yet. Share an insight, caveat, or question.
Kishi et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: